2017 INDEPENDENT SUPPORTED SYMPOSIA

 

The 22nd Annual Meeting and Education Day of the Society for Neuro-Oncology (SNO) will feature multiple Independent Supported Symposia (ISS) Sessions. Lunch-time ISS sessions will be held on Friday and Saturday and an evening ISS session will be held on Friday evening.

FRIDAY, NOVEMBER 17, 2017

LUNCH-TIME ISS SESSION: 12:15PM – 1:15PM

Incorporating New Strategies: Current and Future Directions in Glioblastoma Management
Supported by a grant from Novocure

Location: Yerba Buena Salons 13-15

Chair: Maciej Mrugala, MD, PhD, MPH - Mayo Clinic

Speakers:
Maciej Mrugala, MD, PhD, MPH - Mayo Clinic
Rimas Lukas, MD - Northwestern University
David Reardon, MD- Dana-Farber Cancer Institute

Presentations:
A new look at local therapy in GBM
Rimas Lukas

The impact of immunotherapy in GBM: Now and in the near term
David Reardon

Clinical vignettes revisited and prIME Points™
Maciej Mrugala

For more information and to register, please visit http://www.primeoncology.org/live-education/solid-tumor/sno-gbm-2017/

  

EVENING ISS SESSION: 5:30PM – 7:30PM

NOVALIS CIRCLE SYMPOSIUM - Advanced Imaging and Stereotactic Technologies to Enhance Immunotherapy for Brain Tumors
Supported by Brainlab

Location: Yerba Buena Salons 13 - 15

Speakers:
Michael Lim, MD - Johns Hopkins Medicine
Orin Bloch, MD - Northwestern Memorial Hospital
Gavin Dunn, MD, PhD – Washington University
Andrew Brenner, MD - University of Texas San Antonio

Presentations:
Stereotactic Radiosurgery Combined with Immunotherapy for Recurrent Gliomas
Michael Lim

Surgically-Based Clinical Trials for GBM: Heat Shock Protein Vaccination
Orin Bloch

Stereotactic Image Guided Focused Laser Interstitial Thermal Therapy for Management of GBMs
Gavin Dunn

Intracranial Convection Enhanced Delivery (CED) of Rhenium Nanoliposomes and Delayed Contrast Extravasation MRI for Depicting Tumor and Non-Tumoral Tissues
Andrew Brenner

For more information and to register, please visit https://www.novaliscircle.org/events/

  

SATURDAY, NOVEMBER 18, 2017

LUNCH-TIME ISS SESSIONS: 12:15PM – 1:15PM

Targeting EGFR in Glioblastoma: Where We’ve Been and Where We’re Going
Supported by a grant from AbbVie

Location: Yerba Buena Salons 13 - 15

Chair: David Reardon - Dana-Farber Cancer Institute

Speakers:
David Reardon, MD - Dana-Farber Cancer Institute
John H. Sampson, MD, PhD - Duke University
Andrew Lassman, MD - Columbia University

Presentations:
Molecular classification and the search for targets in GBM
John H. Sampson

Drilling down on EGFR-targeted therapy
Andrew Lassman

prIME Points™
David Reardon

For more information and to register please visit: http://www.primeoncology.org/live-education/solid-tumor/egfr-gbm-2017/

  

EGFR-Targeted Therapy for Leptomeningeal Carcinomatosis in Non-Small Cell Lung Cancer
Supported by a grant from AstraZeneca

Location: Nob Hill CD

Chair: Manmeet Ahluwalia, MD, FAC – Cleveland Clinic

Faculty:
Jeremy Rudnick, MD - Cedars-Sinai Medical Center
Heather Wakelee, MD - Stanford University
Manmeet Ahluwalia, MD, FAC – Cleveland Clinic

Presentations:
Leptomeningeal carcinomatosis in non-small cell lung cancer (NSCLC): The scope of the challenge
Jeremy Rudnick

Examining strategies for leptomeningeal carcinomatosis in EGFR-mutant NSCLC
Heather Wakelee

prIME Points™
Manmeet Ahluwalia

For more information and to register, visit: http://www.primeoncology.org/live-education/solid-tumor/leptomeningeal-carcinomatosis-nsclc-2017/